Desq Long
Sign in
SEC FORM 4
$113,257.29

Definium Therapeutics, Inc. (DFTX)

Sale of 3,097 shares at $36.57 per share.

Reporting Person Wiley Matthew T. · Officer Title Chief Commercial Officer · Transaction Code S

Traded Sep 25, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001104659-26-112061 · filed 2026-09-29 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Definium Therapeutics, Inc. (DFTX)." Disclosed 2026-09-29. https://desqlong.com/cards/0001104659-26-112061-1 (retrieved 2026-09-30).